Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s ANDA Approvals

Executive Summary

Generic drug approvals and tentative approvals for mid-January.

Applicant

Active Ingredients

Number

Date Approved

Macleods

Famciclovir, 125 mg, 250 mg and 500 mg, tabs.

201-022

1/12/2012

Invagen

Alfuzosin HCl, 10 mg extended release, tabs.

90-284

1/17/2012

Tentative Approvals

Sun Pharma Global

Eszopiclone, 1 mg, 2 mg and 3 mg tabs.

91-103

1/12/2012

Amneal

Escitalopram oxalate, 5 mg/ml solution

202-227

1/18/2012

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel